Apellis Pharmaceuticals | 10-Q:2024財年三季報
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Francois Cedric
Apellis Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.1%)
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Watson David O.
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Chopas James George
Apellis Pharmaceuticals | 144:擬議出售證券
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Chopas James George
Apellis Pharmaceuticals | 144:擬議出售證券
Apellis Pharmaceuticals | 4:持股變動聲明-高管 DeLong Mark Jeffrey
Apellis Pharmaceuticals | 8-K:重大事件
Apellis Pharmaceuticals | 10-Q:2024財年二季報
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 144:擬議出售證券
Apellis Pharmaceuticals | 8-K:重大事件
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Deschatelets Pascal
Apellis Pharmaceuticals | 8-K:重大事件
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Deschatelets Pascal
暫無數據
暫無數據